end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccruedLiabilitiesCurrent,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentForAmortization,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AllocatedShareBasedCompensationExpense,Assets,AssetsCurrent,AssetsFairValueDisclosure,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleDebtSecuritiesGrossUnrealizedGain,AvailableForSaleDebtSecuritiesGrossUnrealizedLoss,AvailableForSaleSecurities,AvailableForSaleSecuritiesCurrent,AvailableForSaleSecuritiesDebtSecurities,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,AvailableForSaleSecuritiesGrossRealizedLosses,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsAndShortTermInvestments,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashEquivalentsAtCarryingValue,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue,DebtConversionConvertedInstrumentAmount1,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsValuationAllowance,DefinedContributionPlanEmployerDiscretionaryContributionAmount,Depreciation,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,EmployeeRelatedLiabilitiesCurrent,FairValueAdjustmentOfWarrants,ForeignCurrencyTransactionGainLossBeforeTax,GainLossOnSaleOfInvestments,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InvestmentIncomeInterest,LeaseAndRentalExpense,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LiabilitiesFairValueDisclosure,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OtherAccruedLiabilitiesCurrent,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax,PaymentsForRepurchaseOfCommonStock,PaymentsOfStockIssuanceCosts,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquireInvestments,PaymentsToAcquireMachineryAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromConvertibleDebt,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromSaleMaturityAndCollectionsOfInvestments,ProceedsFromStockOptionsExercised,PropertyPlantAndEquipmentNet,ReclassificationsOfTemporaryToPermanentEquity,RedeemableNoncontrollingInterestEquityPreferredCarryingAmount,ResearchAndDevelopmentExpense,RestrictedCashAndCashEquivalentsAtCarryingValue,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueRestrictedStockAwardGross,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityAccretionOfDividends,TemporaryEquityAccretionToRedemptionValue,TemporaryEquityAccretionToRedemptionValueAdjustment,TemporaryEquityDividendsAdjustment,TemporaryEquityLiquidationPreference,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2020-06-30,2020-09-18,10-Q,"Checkmate Pharmaceuticals, Inc.",CMPI,CIK0001651431,USD,3249000.0,,3736000.0,,,,100000.0,,100000.0,83456000.0,83456000.0,80045000.0,,,,,,,,,80289000.0,,80309000.0,,,14948249.0,0.0001,146000000.0,1488489.0,1488489.0,1000.0,-8348000.0,,,,,,,,,,,,-7.37,,,,,,,,837000.0,,,,1795000.0,,,,6000.0,100000.0,6985000.0,83456000.0,6985000.0,,,,,-8348000.0,-10964000.0,-77000.0,8271000.0,-8271000.0,327000.0,,,,,,,,,,,,3147000.0,,,,,,,,,194268000.0,6476000.0,20000.0,-117798000.0,,,,,426980.0,2.23,,,,906000.0,1073044.0,2.45,1073044.0,2.45,,,,468000.0,,-117797000.0,,,,,2187000.0,,429000.0,2187000.0,193968000.0,108096207.0,108096207.0,,,,,1488489.0
2020-09-30,2020-11-13,10-Q,"Checkmate Pharmaceuticals, Inc.",CMPI,CIK0001651431,USD,3706000.0,,5154000.0,,264344000.0,,852000.0,1600000.0,852000.0,144065000.0,144065000.0,137100000.0,,,,,,,,,137340000.0,,137360000.0,,,,0.0001,300000000.0,21550547.0,21550547.0,2000.0,-9829000.0,,,,,,,,,,,,-0.84,,,,,,,,1600000.0,,,,3160000.0,,,,4000.0,100000.0,8860000.0,144065000.0,8860000.0,,,,,-9829000.0,-11413000.0,4000.0,9833000.0,-9833000.0,177000.0,,,,1900000.0,,,,0.0001,10000000.0,0.0,0.0,6705000.0,,,,,,,,195847000.0,,6673000.0,20000.0,-129141000.0,,,,,484458.0,2.61,,,,9681000.0,2491336.0,9.48,2491336.0,9.48,,,,4357000.0,,135205000.0,,67712000.0,,4000.0,1579000.0,,5000.0,1579000.0,,,,,,,,13580105.0
2020-12-31,2021-03-29,10-K,"Checkmate Pharmaceuticals, Inc.",CMPI,CIK0001651431,USD,2297000.0,-188000.0,5578000.0,-74000.0,265342000.0,,2035000.0,,2035000.0,133074000.0,102101000.0,91643000.0,83878000.0,8000.0,82000.0,52831000.0,51831000.0,83804000.0,30973000.0,,43055000.0,125900000.0,43075000.0,38870000.0,8800000.0,,0.0001,300000000.0,21560398.0,21560398.0,2000.0,-36982000.0,0.0,,35731000.0,0.0,30120000.0,4891000.0,108000.0,612000.0,35731000.0,100000.0,,-4.49,0.0,0.21,-0.2647,0.0,-0.0111,0.0461,0.0197,1555000.0,,100000.0,,10185000.0,63000.0,2477000.0,6049000.0,79000.0,500000.0,7875000.0,133074000.0,7875000.0,,160271000.0,-83290000.0,-38111000.0,-36908000.0,-42905000.0,-4000.0,36904000.0,-36904000.0,390000.0,-74000.0,0.0,,,83290000.0,,,0.0001,10000000.0,0.0,0.0,7195000.0,10000000.0,67712000.0,82539000.0,,,20000.0,,195847000.0,,26719000.0,20000.0,-140071000.0,2035000.0,0.0,0.7884,0.0031,604386.0,2.66,43816.0,,1522248.0,13177000.0,2537669.0,9.61,2537669.0,9.61,1.43,6.87,14.5,7216000.0,,125199000.0,13807.0,67712000.0,,20000.0,5536000.0,461000.0,461000.0,5536000.0,,,,1307000.0,0.0,1307000.0,9800000.0,9559898.0
2021-03-31,2021-05-13,10-Q,"Checkmate Pharmaceuticals, Inc.",CMPI,CIK0001651431,USD,2086000.0,,5225000.0,-83000.0,266676000.0,202000.0,1216000.0,,1216000.0,119707000.0,94060000.0,99212000.0,72414000.0,3000.0,86000.0,,46684000.0,72331000.0,25647000.0,,39127000.0,111500000.0,39147000.0,-3928000.0,,,0.0001,300000000.0,21619623.0,21619623.0,2000.0,-14137000.0,,,,,,,,,,,,-0.65,,,,,,,,1107000.0,,,,3803000.0,-210000.0,-354000.0,1033000.0,53000.0,100000.0,7311000.0,119707000.0,7311000.0,,118000.0,10261000.0,-14307000.0,-14128000.0,-14128000.0,53000.0,14181000.0,-14181000.0,356000.0,-9000.0,,,,,10239000.0,,0.0001,10000000.0,0.0,0.0,8229000.0,,,,,20500000.0,118000.0,,,,10378000.0,20000.0,-154199000.0,1216000.0,,,,,,,728500.0,,,,,,,,,13.85,,9.64,112396000.0,,,,118000.0,,,,,,,,,,,,21582143.0
2021-06-30,2021-08-12,10-Q,"Checkmate Pharmaceuticals, Inc.",CMPI,CIK0001651431,USD,2198000.0,,4504000.0,-33000.0,268179000.0,,1487000.0,,1487000.0,101681000.0,91074000.0,94387000.0,32513000.0,,,22240000.0,22240000.0,32480000.0,10240000.0,35000.0,63110000.0,95600000.0,63130000.0,,,,0.0001,300000000.0,21625891.0,21625891.0,2000.0,-18920000.0,0.0,,,,,,,,,,,-0.88,,,,,,,,1677000.0,,,,4090000.0,,,,20000.0,200000.0,6702000.0,101681000.0,6702000.0,,,,,-18970000.0,-18970000.0,-15000.0,18955000.0,-18955000.0,750000.0,50000.0,,,,,,,0.0001,10000000.0,0.0,,5704000.0,,,,,,,367000.0,,,14865000.0,20000.0,-173169000.0,,,,,,,,,,,,,,,,,,,,94979000.0,,,,16000.0,,,,,,,,,,,,21624568.0
2021-09-30,2021-11-12,10-Q,"Checkmate Pharmaceuticals, Inc.",CMPI,CIK0001651431,USD,2521000.0,,5291000.0,-2000.0,269662000.0,,1480000.0,,1480000.0,89339000.0,88671000.0,79599000.0,27352000.0,,,27350000.0,27350000.0,27350000.0,0.0,,53494000.0,80800000.0,53514000.0,,,,0.0001,300000000.0,21626891.0,21626891.0,2000.0,-14935000.0,0.0,,,,,,,,,,,-0.69,,,,,,,,1601000.0,,,,3605000.0,,,,14000.0,200000.0,7812000.0,89339000.0,7812000.0,,,,,-14966000.0,-14966000.0,14000.0,14980000.0,-14980000.0,537000.0,31000.0,,,,,,,0.0001,10000000.0,0.0,,7807000.0,,,,,,,668000.0,,,11375000.0,20000.0,-188135000.0,,,,,,,,,,,,,,,,,,,,81527000.0,,0.0,,3000.0,,,,,,,,,,,,21625902.0
